Highlighted PresentationsStructural heart diseaseValvular Aortic valve

SOLACI-SBHCI 2023 | TAVR – Lifetime Management of Patients with Aortic Stenosis – Dr. Ole de Backer

solaci
solaci
692
0

Read the most outstanding articles from SOLACI-SBHCI 2023 Congress.

In this case, check the presentation by Dr. Ole de Backer, entitled “TAVR – Lifetime Management of Patients with Aortic Stenosis”

Ole-de-backer-copacabana-room-lifetime-management-solaci-sbhci-2023

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Previous article
SOLACI-SBHCI 2023 | Insights from the LATAM Peripheral Registry – Dr. Maximiliano Rossi
Next article
SOLACI-SBHCI 2023 | TAVI – Minimizing Risks, Optimizing Outcomes & Impact of the Index Procedure on Future Options – Dr. Ole De Backer
solaci
solaci

More articles by this author

Coronary artery disease progression after transcatheter aortic valve replacement: quantitative coronary angiography and Quantitative Flow Ratio analysis

Dr. Juan Manuel Pérez - 0
The coexistence of coronary artery disease and severe aortic stenosis is common among patients undergoing transcatheter aortic valve replacement (TAVR). However, the impact of...

UNICORN Technique to Prevent Coronary Obstruction During TAVI: Initial Results From a Multicenter Study

Dr. Juan Manuel Pérez - 0
Coronary obstruction is an uncommon but potentially catastrophic complication of transcatheter aortic valve implantation (TAVI), particularly in valve-in-valve procedures, TAV-in-TAV interventions, or in patients...

Hemodynamic Outcomes of Edge-to-Edge Repair in Degenerative and Functional Mitral Regurgitation

Dr. Andrés Rodríguez - 0
Transcatheter edge-to-edge mitral valve repair (M-TEER) has become an established therapeutic option for mitral valve disease. Among the available techniques, M-TEER using the MitraClip...

SAPIEN 3 TAVI Durability: Ten-Year Follow-Up in Intermediate-Risk Patients

Dr. Omar Tupayachi - 0
The durability of transcatheter bioprosthetic valves used in TAVI remains one of the key unanswered questions as indications continue to expand toward patients with...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Structural heart disease

Coronary artery disease progression after transcatheter aortic valve replacement: quantitative coronary angiography and Quantitative Flow Ratio analysis

The coexistence of coronary artery disease and severe aortic stenosis is common among patients undergoing transcatheter aortic valve replacement (TAVR)....
Dr. Juan Manuel Pérez -
SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Coronary artery disease progression after transcatheter aortic valve replacement: quantitative coronary angiography and Quantitative Flow Ratio analysis

Dr. Juan Manuel Pérez - 0
The coexistence of coronary artery disease and severe aortic stenosis is common among patients undergoing transcatheter aortic valve replacement (TAVR). However, the impact of...

UNICORN Technique to Prevent Coronary Obstruction During TAVI: Initial Results From a Multicenter Study

Dr. Juan Manuel Pérez - 0
Coronary obstruction is an uncommon but potentially catastrophic complication of transcatheter aortic valve implantation (TAVI), particularly in valve-in-valve procedures, TAV-in-TAV interventions, or in patients...

Supera vs. Eluvia at 3 Years in Severely Calcified Femoropopliteal Lesions

Dr. Juan Manuel Pérez - 0
Severe calcification remains one of the main predictors of restenosis and the need for repeat revascularization following endovascular treatment of femoropopliteal disease. In this...